These results clearly link TCC exposure to activation of ERα target genes, Cyp1b1/CYP1B1 and Cyp2b10/CYP2B6 in both cultured human breast cancer cells and in vivo estrogen-sensitive tissues. This evidence concerns the gene CYP2B6 and breast cancer.